Literature DB >> 18206277

The demand for a dengue vaccine: a contingent valuation survey in Metro Manila.

Rosalina Palanca-Tan1.   

Abstract

Using data gathered from a contingent valuation survey, this study estimated the willingness to pay (WTP) for a single dengue fever vaccine and the household demand function for dengue vaccines. Mean WTP for the vaccine ranged from US$27 to US$32 and household demand averaged 2 per household. Our findings indicate sufficiently high WTP for dengue vaccines and hence a significant potential for selling the vaccine in private markets. For the lower income groups with lower capacity to pay, a mass vaccination campaign program in which part of the financial costs are covered by vaccine user charges is viable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18206277     DOI: 10.1016/j.vaccine.2007.12.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Forecasting dengue vaccine demand in disease endemic and non-endemic countries.

Authors:  Ananda Amarasinghe; Ole Wichmann; Harold S Margolis; Richard T Mahoney
Journal:  Hum Vaccin       Date:  2010-09-01

Review 2.  Dengue vaccine acceptance and willingness to pay.

Authors:  Harapan Harapan; Jonny K Fajar; R Tedjo Sasmono; Ulrich Kuch
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

3.  A Multi-country Study of the Household Willingness-to-Pay for Dengue Vaccines: Household Surveys in Vietnam, Thailand, and Colombia.

Authors:  Jung-Seok Lee; Vittal Mogasale; Jacqueline K Lim; Mabel Carabali; Chukiat Sirivichayakul; Dang Duc Anh; Kang-Sung Lee; Vu Dinh Thiem; Kriengsak Limkittikul; Le Huu Tho; Ivan D Velez; Jorge E Osorio; Pornthep Chanthavanich; Luiz J da Silva; Brian A Maskery
Journal:  PLoS Negl Trop Dis       Date:  2015-06-01

4.  Consumer willingness to invest money and time for benefits of lifestyle behaviour change: an application of the contingent valuation method.

Authors:  Adrienne F G Alayli-Goebbels; Job van Exel; André J H A Ament; Nanne K de Vries; Sandra D M Bot; Johan L Severens
Journal:  Health Expect       Date:  2014-08-18       Impact factor: 3.377

5.  Hypothetical assessment of efficiency, willingness-to-accept and willingness-to-pay for dengue vaccine and treatment: a contingent valuation survey in Bangladesh.

Authors:  K M Ariful Kabir; Aya Hagishima; Jun Tanimoto
Journal:  Hum Vaccin Immunother       Date:  2020-08-21       Impact factor: 3.452

6.  Allosteric inhibition of the NS2B-NS3 protease from dengue virus.

Authors:  Muslum Yildiz; Sumana Ghosh; Jeffrey A Bell; Woody Sherman; Jeanne A Hardy
Journal:  ACS Chem Biol       Date:  2013-10-28       Impact factor: 5.100

7.  Parents' willingness to pay for a COVID-19 vaccine for themselves and their children in the United States.

Authors:  Serkan Catma; Diana Reindl
Journal:  Hum Vaccin Immunother       Date:  2021-04-30       Impact factor: 3.452

Review 8.  Health economics of dengue: a systematic literature review and expert panel's assessment.

Authors:  Mark E Beatty; Philippe Beutels; Martin I Meltzer; Donald S Shepard; Joachim Hombach; Raymond Hutubessy; Damien Dessis; Laurent Coudeville; Benoit Dervaux; Ole Wichmann; Harold S Margolis; Joel N Kuritsky
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

9.  Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia.

Authors:  Panji Fortuna Hadisoemarto; Marcia C Castro
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19

Review 10.  Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Authors:  Rohan Deogaonkar; Raymond Hutubessy; Inge van der Putten; Silvia Evers; Mark Jit
Journal:  BMC Public Health       Date:  2012-10-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.